EIF2AK4 Gene Pulmonary Venoocclusive Disease Type 2 Genetic Test
At DNA Labs UAE, we offer the EIF2AK4 Gene Pulmonary Venoocclusive Disease Type 2 Genetic Test. This test is designed to detect the presence of the EIF2AK4 gene associated with pulmonary venoocclusive disease type 2 (PVOD2).
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Cardiovascular Pneumology Disorders
- Doctor: Cardiologist
- Test Department: Genetics
Pre Test Information
Prior to undergoing the EIF2AK4 Gene Pulmonary Venoocclusive Disease Type 2 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by PVOD2.
Test Details
The EIF2AK4 gene is associated with pulmonary venoocclusive disease type 2 (PVOD2), a rare genetic disorder that affects the blood vessels in the lungs. This leads to high blood pressure in the pulmonary arteries. The NGS genetic testing method, which utilizes advanced sequencing technologies, is used to analyze multiple genes simultaneously.
In the context of PVOD2, NGS genetic testing can identify mutations or variations in the EIF2AK4 gene that may be responsible for the disease. This information is crucial for diagnosing PVOD2, determining the risk of developing the disease, and providing guidance for genetic counseling and family planning.
NGS testing also aids in the development of personalized treatment strategies for individuals with PVOD2. It is important to note that this genetic testing should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.
Test Name | EIF2AK4 Gene Pulmonary venoocclusive disease type 2 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cardiovascular Pneumology Disorders |
Doctor | Cardiologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for EIF2AK4 Gene Pulmonary venoocclusive disease type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EIF2AK4 Gene Pulmonary venoocclusive disease type 2 NGS Genetic DNA Test gene EIF2AK4 |
Test Details |
The EIF2AK4 gene is associated with pulmonary venoocclusive disease type 2 (PVOD2). PVOD2 is a rare genetic disorder that affects the blood vessels in the lungs, leading to high blood pressure in the pulmonary arteries. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the context of PVOD2, NGS genetic testing can be used to identify mutations or variations in the EIF2AK4 gene that may be responsible for the disease. By identifying these genetic variations, NGS testing can help in diagnosing PVOD2, determining the risk of developing the disease, and providing information for genetic counseling and family planning. It can also aid in the development of personalized treatment strategies for individuals with PVOD2. It is important to note that NGS genetic testing should be performed by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support. |